Ronit Satchi-Fainaro

Affiliations: 
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel 
Google:
"Ronit Satchi-Fainaro"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Koshrovski-Michael S, Ajamil DR, Dey P, et al. (2024) Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers. Science Advances. 10: eadr4762
Madan E, Palma AM, Vudatha V, et al. (2024) Ovarian tumor cells gain competitive advantage by actively reducing the cellular fitness of microenvironment cells. Nature Biotechnology
Liubomirski Y, Tiram G, Scomparin A, et al. (2024) Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker. Journal of Controlled Release : Official Journal of the Controlled Release Society
Matos AI, Peres C, Carreira B, et al. (2023) Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2300299
Ofek P, Yeini E, Arad G, et al. (2023) Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma. International Journal of Cancer
Epshtein Y, Blau R, Pisarevsky E, et al. (2022) Polyglutamate-based nanoconjugates for image-guided surgery and post-operative melanoma metastases prevention. Theranostics. 12: 6339-6362
Pozzi S, Scomparin A, Ben-Shushan D, et al. (2022) MCP-1/CCR2 axis inhibition sensitizes the brain microenvironment against melanoma brain metastasis progression. Jci Insight
Krivitsky A, Pozzi S, Yeini E, et al. (2021) Sulfonated Amphiphilic Poly(α)glutamate Amine-A Potential siRNA Nanocarrier for the Treatment of Both Chemo-Sensitive and Chemo-Resistant Glioblastoma Tumors. Pharmaceutics. 13
Neufeld L, Yeini E, Reisman N, et al. (2021) Microengineered perfusable 3D-bioprinted glioblastoma model for in vivo mimicry of tumor microenvironment. Science Advances. 7
Pozzi S, Scomparin A, Israeli-Dangoor S, et al. (2021) Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development? Advanced Drug Delivery Reviews
See more...